Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
8.26
-0.27 (-3.17%)
At close: Nov 7, 2025, 4:00 PM EST
8.24
-0.02 (-0.24%)
After-hours: Nov 7, 2025, 7:51 PM EST
Biohaven Market Cap
Biohaven has a market cap or net worth of $873.83 million as of November 7, 2025. Its market cap has decreased by -83.53% in one year.
Market Cap
873.83M
Enterprise Value
503.35M
1-Year Change
-83.53%
Ranking
Category
Stock Price
$8.26
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $873.83M, an increase of 234.06%. That is a compound annual growth rate of 47.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 873.83M | -76.86% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |